Wockhardt gets USFDA approval for marketing Metoprolol succinate Bangalore, Jul 23 : Pharmaceutical and Biotechnology major Wockhardt has received final approval from the United States Food and Drug Administration (USFDA) for marketing 25mg, 50mg, 100mg and 200mg extended-release tablets of Metoprolol succinate, a cardiac drug. Read more on New Kerala Sanofi may buy Genzyme...